Vericel to Present at the 2019 UBS Global Healthcare Conference on Wednesday, May 22, 2019

World News: . []

CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the 2019 UBS Global Healthcare Conference in New York City on Wednesday, May 22, 2019 at 10:30am Eastern Time.

A live webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at:

Epicel and MACI are registered trademarks of Vericel Corporation. © 2019 Vericel Corporation. NexoBrid is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. All rights reserved.

Karen ChaseRusso Partners LLCKaren.chase@russopartnersllc.com+1 646-942-5627 (office)+1 917-547-0434 (mobile)

Lee SternSolebury Troutlstern@troutgroup.com+1 646-378-2922

More news and information about Vericel Corporation

Published By:

Globe Newswire: 13:00 GMT Wednesday 15th May 2019

Published: .

Search for other references to "vericel" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us